Pulmonary Pharmacology (eBook, ePUB)

• Format: ePub

Produktbeschreibung

Pulmonary Pharmacology, Volume 98 provides in-depth reviews on the latest progresses about respiratory drug discovery and development. Topics covered in this volume include corticosteroids, monoclonal antibodies, tyrosine kinase inhibitors and phosphodiesterase inhibitors for the treatments of asthma, COPD or pulmonary fibrosis, with perspective on the development of novel therapeutic strategies such as renin-angiotensin system modulators, mitochondrial function modulators, and non-antibacterial macrolides. Part of the volume is devoted to senotherapy for lung ageing in respiratory diseases, and novel pulmonary delivery technologies, including inhaled biologics.

• Provides accurate reviews from leading experts on the topic of pulmonary pharmacology
• Each chapter of the volume provides consolidated graphical materials for ease of reading for the audience
• Provides the latest insights and future perspectives on the drug discovery and development for respiratory diseases

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Elsevier Science & Techn.
• Seitenzahl: 312
• Erscheinungstermin: 1. August 2023
• Englisch
• ISBN-13: 9780443188817
• Artikelnr.: 68530119

Inhaltsangabe

Preface W.S. FRED WONG 1. Genomic and non-genomic effects of glucocorticoids in respiratory diseases Zhao-Yong Lee and Thai Tran 2. Recent developments in the use of monoclonal antibodies targeting the type 2 cytokines for severe asthma treatment Garry M. Walsh 3. Phosphodiesterase inhibitors and lung diseases Ivana Stolfa and Clive Page 4. Prospects for macrolide therapy of asthma and COPD Michael J. Parnham
Virginia Norris
Jennifer A. Kricker
Thorarinn Gudjonsson
and Clive P. Page 5. Targeting the renin angiotensin system for respiratory diseases Phyllis X.L. Gan
W. Liao
Kira M. Linke
D. Meid
X.D. Wu
and W.S. Fred Wong 6. Progress in the development of kinase inhibitors for treating asthma and COPD Nathaniel McClean
Jeffery D. Hasday
and Paul Shapiro 7. Anti-fibrotic strategies and pulmonary fibrosis Avanka Gunatilaka
Stephanie Zhang
Wan Shun Daniel Tan
and Alastair G. Stewart 8. Novel treatments against airway inflammation in COPD based on drug repurposing Rui Chen
Yuting Cui
and Judith C.W. Mak 9. Senotherapy for lung diseases Peter J. Barnes 10. Delivery technology of inhaled therapy for asthma and COPD Michael Y.T. Chow
Harry W. Pan
and Jenny K.W. Lam